TraceLink, a Wakefield, MA-based provider of pharmaceutical serialization, track and trace and supply network towers for global Life Sciences, raised $5.5m in growth capital.
The round was led by FirstMark Capital.
The company intends to use the funds to accelerate development and deployment of its solutions.
Led by Shabbir Dahod, President and CEO, TraceLink provides an Amazon AWS-based cloud application platform which enables complete global connectivity, visibility and traceability of pharmaceuticals from raw materials to patient.
The company provides customers across the Life Sciences supply chain, including pharmaceutical companies, CMO/CPOs, 3PLs, wholesale distributors and pharmacies, with solutions that combine serialization, government reporting, network connectivity and transaction monitoring tools to ensure regulatory compliance, monitor drug quality and reach global markets.